Log in to save to my catalogue

Alternative splicing of interleukin-33 and type 2 inflammation in asthma

Alternative splicing of interleukin-33 and type 2 inflammation in asthma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4978244

Alternative splicing of interleukin-33 and type 2 inflammation in asthma

About this item

Full title

Alternative splicing of interleukin-33 and type 2 inflammation in asthma

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2016-08, Vol.113 (31), p.8765-8770

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Type 2 inflammation occurs in a large subgroup of asthmatics, and novel cytokine-directed therapies are being developed to treat this population. In mouse models, interleukin-33 (IL-33) activates lung resident innate lymphoid type 2 cells (ILC2s) to initiate airway type 2 inflammation. In human asthma, which is chronic and difficult to model, the r...

Alternative Titles

Full title

Alternative splicing of interleukin-33 and type 2 inflammation in asthma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4978244

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4978244

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1601914113

How to access this item